Illumina, Inc. (NASDAQ:ILMN) announced its quarterly earnings results on Thursday, April, 25th. The life sciences company reported $1.60 EPS for the quarter, beating the Zacks' consensus estimate of $1.34 by $0.26. The life sciences company earned $846 million during the quarter, compared to analysts' expectations of $838.70 million. Illumina had a return on equity of 23.49% and a net margin of 25.06%. Illumina's revenue was up 8.2% compared to the same quarter last year. During the same period in the prior year, the company earned $1.45 EPS.
NASDAQ:ILMN - Stock Price, News, & Analysis for Illumina
